David Berry

Insider Reports History

Location
C/O Eleven Biotherapeutics, Inc., 215 First Street, Suite 400, Cambridge, MA
Signature
/s/ David Berry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Berry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Director Common Stock 53.1K $425K $8.00 Aug 3, 2021 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 19.9K Jul 29, 2021 Direct

Insider Reports Filed by David Berry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OACC Oaktree Acquisition Corp. III Life Sciences Oct 17, 2025 0 $0 3 Oct 22, 2025 Director
OMGA Omega Therapeutics, Inc. Aug 3, 2021 1 $902K 4 Aug 3, 2021 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 1 $0 4 Jul 30, 2021 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director